• Hepatitis B Virus (HBV) by Molecular Method, Qualitative
  • Alpha 1 Microglobulin, 24 Hour, Urine
  • Adrenoceptor Alpha 2A Polymorphism (ADRA2A)
  • Thyrotropin Releasing Hormone (TRH)
  • Aspergillus (Galactomannan) Antigen, Serum
  • Brain-derived Neurotrophic Factor (BDNF) Genotyping
  • Tobramycin, Trough, Serum
  • Burkitt Lymphoma Genetic Testing, FISH, Tissue
  • T-Cell Receptor Gene Rearrangement, Flow Cytometry, Blood
  • Porphobilinogen, Quantitative, Random, Urine
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /RET Proto Oncogene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

RET Proto Oncogene Mutation Analysis
Medical Test

Clinical Utility
Access to RET Proto Oncogene Mutation Analysis is restricted.